Expert Interview
A Third Opinion: Discussing the potential of Fractyl Health's lead drug candidate Rejuva, an adeno-associated virus (AAV)-based GLP-1 pancreatic gene therapy.
Ticker(s): GUTS, NVO, LLY- Former Manager, Chief Health Officer, Community Care at Cityblock Health and currently Co-founder and CEO of Sevi Health.
- 10 years of experience in healthcare management, he leads the vision, strategy, and execution of Sevi Health, aiming to improve access, quality, and affordability of primary care.
- Passionate about value-based care and data-driven quality improvement, and has a proven track record of leading and scaling innovative healthcare models and partnerships.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
